dalteparin has been researched along with Tibial Fractures in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Tibial Fractures: Fractures of the TIBIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsukanov, IuT | 1 |
| Noskov, VK | 1 |
| Dziuba, GG | 1 |
| Epanchintsev, PM | 1 |
| Latacz, P | 1 |
| Rostoff, P | 1 |
| Wyderka, R | 1 |
| Rudnik, A | 1 |
| Kondys, M | 1 |
| Marut, A | 1 |
| Buszman, P | 1 |
| Piwowarska, W | 1 |
| Suto, Y | 1 |
| Nagata, K | 1 |
| Ahmed, SM | 1 |
| Jacovides, C | 1 |
| Browne, KD | 1 |
| Cognetti, J | 1 |
| Weber, MT | 1 |
| Johnson, VE | 1 |
| Leone, R | 1 |
| Kaplan, LJ | 1 |
| Smith, DH | 1 |
| Pascual, JL | 1 |
| Sems, SA | 1 |
| Levy, BA | 1 |
| Dajani, K | 1 |
| Herrera, DA | 1 |
| Templeman, DC | 1 |
| McLaughlin, JA | 1 |
| Paulson, MM | 1 |
| Rosenthal, RE | 1 |
| Selby, R | 1 |
| Geerts, WH | 1 |
| Kreder, HJ | 1 |
| Crowther, MA | 1 |
| Kaus, L | 1 |
| Sealey, F | 1 |
| Goel, DP | 1 |
| Buckley, R | 1 |
| deVries, G | 1 |
| Abelseth, G | 1 |
| Ni, A | 1 |
| Gray, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures: Epidemiology & Prevention[NCT00187408] | Phase 4 | 700 participants | Interventional | 2002-08-31 | Completed | ||
| A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients[NCT02774265] | Phase 3 | 329 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
DVT and how the diagnosis was made will be recorded. The number of events in participants in each arm will be compared to evaluate efficacy. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 5 |
| VTE Prophylaxis With Aspirin 81mg BID | 9 |
Bases on imaging obtained for symptoms. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 6 |
| VTE Prophylaxis With Aspirin 81mg BID | 2 |
Includes a greater than 2g/dL drop in hemoglobin, blood transfusion, hematoma evacuation, re-operation for a deep surgical site infection or minor procedure for bleeding and GI bleed (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 52 |
| VTE Prophylaxis With Aspirin 81mg BID | 53 |
2 trials available for dalteparin and Tibial Fractures
| Article | Year |
|---|---|
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomised controlled trial.
Topics: Adult; Aged; Ankle Injuries; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fractures, Bon | 2009 |
5 other studies available for dalteparin and Tibial Fractures
| Article | Year |
|---|---|
[Outcomes of prolonged anticoagulant prevention of thrombosis of deep veins of the crus in closed comminuted fractures of tibial bones].
Topics: Anticoagulants; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Fractures, Closed; Frac | 2009 |
[Massive pulmonary embolism mimicking ST-elevation acute coronary syndrome successfully treated with hybrid therapy in a trauma patient receiving nadroparin: diagnostic and therapeutic dilemmas].
Topics: Acute Coronary Syndrome; Angiocardiography; Angioplasty, Balloon; Diagnosis, Differential; Drug Ther | 2007 |
A concomitant bone fracture delays cognitive recovery from traumatic brain injury.
Topics: Animals; Behavior, Animal; Brain; Brain Injuries, Traumatic; Cognition; Disease Models, Animal; Enox | 2018 |
Incidence of deep venous thrombosis after temporary joint spanning external fixation for complex lower extremity injuries.
Topics: Adult; Anticoagulants; Clinical Protocols; Enoxaparin; External Fixators; Female; Fibula; Fracture F | 2009 |
Delayed onset of anterior tibial compartment syndrome in a patient receiving low-molecular-weight heparin. A case report.
Topics: Adult; Anterior Compartment Syndrome; Anticoagulants; Enoxaparin; Femoral Fractures; Humans; Male; P | 1998 |